MedStar Authors catalog › Details for: TCT-416 In vivo assessment of endothelial-dependent vasomotion in a coronary segment treated by the Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial.
Normal view MARC view ISBD view

TCT-416 In vivo assessment of endothelial-dependent vasomotion in a coronary segment treated by the Second-Generation Drug-Eluting Absorbable Metal Scaffold (DREAMS 2G): Insights from the BIOSOLVE-II First-In-Man Trial.

by Garcia-Garcia, Hector M; Waksman, Ron.
Citation: Journal of the American College of Cardiology. 68(18S):B168, 2016 Nov 01.Journal: Journal of the American College of Cardiology.Published: 2016ISSN: 0735-1097.Full author list: Haude M; Degen H; Garcia-Garcia HM; Waksman R; Stieler M.UI/PMID: 27969766.Subject(s): IN PROCESS -- NOT YET INDEXEDInstitution(s): MedStar Heart & Vascular InstituteActivity type: Journal Article.Medline article type(s): Journal ArticleOnline resources: Click here to access online Digital Object Identifier: https://dx.doi.org/10.1016/j.jacc.2016.09.551 (Click here) Abbreviated citation: J Am Coll Cardiol. 68(18S):B168, 2016 Nov 01.Local Holdings: Available online from MWHC library: 1995 - present, Available in print through MWHC library:1999-2007.

Powered by Koha